rs74675534
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_003848.4(SUCLG2):āc.302A>Gā(p.Lys101Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00778 in 1,612,796 control chromosomes in the GnomAD database, including 68 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0048 ( 2 hom., cov: 32)
Exomes š: 0.0081 ( 66 hom. )
Consequence
SUCLG2
NM_003848.4 missense
NM_003848.4 missense
Scores
1
9
8
Clinical Significance
Conservation
PhyloP100: 7.99
Genes affected
SUCLG2 (HGNC:11450): (succinate-CoA ligase GDP-forming subunit beta) This gene encodes a GTP-specific beta subunit of succinyl-CoA synthetase. Succinyl-CoA synthetase catalyzes the reversible reaction involving the formation of succinyl-CoA and succinate. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 5 and 12. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.019182414).
BP6
Variant 3-67529111-T-C is Benign according to our data. Variant chr3-67529111-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 257601.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUCLG2 | NM_003848.4 | c.302A>G | p.Lys101Arg | missense_variant | 3/11 | ENST00000307227.10 | NP_003839.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUCLG2 | ENST00000307227.10 | c.302A>G | p.Lys101Arg | missense_variant | 3/11 | 1 | NM_003848.4 | ENSP00000307432 | P1 | |
SUCLG2 | ENST00000493112.5 | c.302A>G | p.Lys101Arg | missense_variant | 3/11 | 1 | ENSP00000419325 | |||
SUCLG2 | ENST00000492795.1 | c.302A>G | p.Lys101Arg | missense_variant | 3/10 | 2 | ENSP00000417589 |
Frequencies
GnomAD3 genomes AF: 0.00482 AC: 733AN: 152128Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
733
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00482 AC: 1198AN: 248596Hom.: 7 AF XY: 0.00497 AC XY: 670AN XY: 134852
GnomAD3 exomes
AF:
AC:
1198
AN:
248596
Hom.:
AF XY:
AC XY:
670
AN XY:
134852
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00809 AC: 11820AN: 1460550Hom.: 66 Cov.: 30 AF XY: 0.00788 AC XY: 5726AN XY: 726532
GnomAD4 exome
AF:
AC:
11820
AN:
1460550
Hom.:
Cov.:
30
AF XY:
AC XY:
5726
AN XY:
726532
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00481 AC: 733AN: 152246Hom.: 2 Cov.: 32 AF XY: 0.00390 AC XY: 290AN XY: 74434
GnomAD4 genome
AF:
AC:
733
AN:
152246
Hom.:
Cov.:
32
AF XY:
AC XY:
290
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
40
ALSPAC
AF:
AC:
38
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
86
ExAC
AF:
AC:
574
Asia WGS
AF:
AC:
5
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Benign
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
0.14
.;B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at